Tag: Sorafenib

AstraZeneca’s IMFINZI/IMJUDO shows sustained OS in Phase 3 liver cancer study

businessnewstoday- June 29, 2023

AstraZeneca's IMFINZI (durvalumab) combined with IMJUDO (tremelimumab-actl) has demonstrated an enduring overall survival (OS) benefit in patients with advanced hepatocellular carcinoma (HCC), according to the ... Read More

Dr. Reddy’s Laboratories launches sorafenib generic in US

pallavi123- June 14, 2022

Dr. Reddy’s Laboratories said that it has launched Dr. Reddy’s Sorafenib Tablets, USP, 200 mg in the US market following the approval of the US ... Read More

FDA approves Opdivo + Yervoy for HCC previously treated with sorafenib

pharmanewsdaily- March 12, 2020

Bristol Myers Squibb has secured approval for the combination of Opdivo (nivolumab) 1 mg/kg and Yervoy (ipilimumab) 3 mg/kg from the US Food and Drug ... Read More